Стійкий галюциногенний розлад сприйняття (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Стійкий галюциногенний розлад сприйняття" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

51nih.gov

4^th place

5^th place

40doi.org

2^nd place

4^th place

9archive.org

6^th place

2visualsnowinitiative.org

low place

2perception.foundation

low place

2doctorsonly.co.il

low place

2youtube.com

9^th place

7^th place

1harvard.edu

18^th place

74^th place

1dana.org

low place

1neurogroup.org

low place

1thecut.com

1,562^nd place

low place

1rarediseases.org

5,181^st place

low place

1aspetjournals.org

6,663^rd place

6,498^th place

1buffalostate.edu

low place

archive.org

Further observations on untoward reactions to LSD. The American Journal of Psychiatry. 124 (3): 393—395. September 1967. doi:10.1176/ajp.124.3.393. PMID 6066637. {{cite journal}}: Недійсний |displayauthors=Robbins E, Frosch WA, Stern M (довідка)
Flashbacks: recurrent intrusive images after the use of LSD. The American Journal of Psychiatry. 126 (4): 565—569. October 1969. doi:10.1176/ajp.126.4.565. PMID 5806803. {{cite journal}}: Недійсний |displayauthors=Horowitz MJ (довідка)
Adverse consequences of lysergic acid diethylamide. Addiction. 88 (10): 1327—1334. October 1993. doi:10.1111/j.1360-0443.1993.tb02018.x. PMID 8251869. {{cite journal}}: Недійсний |displayauthors=Abraham HD, Aldridge AM (довідка)
The relation between migraine, typical migraine aura and "visual snow". Headache. 54 (6): 957—966. June 2014. doi:10.1111/head.12378. PMID 24816400. {{cite journal}}: Недійсний |displayauthors=Schankin CJ, Maniyar FH, Sprenger T, Chou DE, Eller M, Goadsby PJ (довідка)
A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology. 147 (2): 200—209. November 1999. doi:10.1007/s002130051161. PMID 10591888. {{cite journal}}: Недійсний |displayauthors=Mintzer MZ, Stoller KB, Griffiths RR (довідка)
Tripping into trauma: Cognitive-behavioural treatment for a traumatic stress reaction following recreational drug use.. A casebook of cognitive therapy for traumatic stress reactions. Routledge/Taylor & Francis Group. 2009. с. 49–60.
Introduction to Part II. The thaw : reclaiming the person for psychiatry (вид. 2nd, rev. & expanded). Hillsdale, NJ: Analytic Press. 2002. doi:10.4324/9780203767238. ISBN 978-0-203-76723-8.
Cognitive-behaviour therapy for depersonalisation disorder: an open study. Behaviour Research and Therapy. 43 (9): 1121—1130. September 2005. doi:10.1016/j.brat.2004.08.003. PMID 16005701. {{cite journal}}: Недійсний |displayauthors=Hunter EC, Baker D, Phillips ML, Sierra M, David AS (довідка)
Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behaviour Research and Therapy. 41 (12): 1451—1467. December 2003. doi:10.1016/s0005-7967(03)00066-4. PMID 14583413. {{cite journal}}: Недійсний |displayauthors=Hunter EC, Phillips ML, Chalder T, Sierra M, David AS (довідка)

aspetjournals.org

jpet.aspetjournals.org

Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. The Journal of Pharmacology and Experimental Therapeutics. 246 (3): 924—928. September 1988. PMID 2843634. {{cite journal}}: Недійсний |displayauthors=Sanders-Bush E, Burris KD, Knoth K (довідка)

buffalostate.edu

digitalcommons.buffalostate.edu

The United States Print Media and its War on Psychedelic Research in the 1960s. The Exposition. 5 (1): 2. 2019. {{cite journal}}: Недійсний |displayauthors=Bracco JM (довідка)

dana.org

When the Trip Never Ends. Dana Foundation. 29 квітня 2013.

doctorsonly.co.il

Flashbacks and HPPD: A Clinical-oriented Concise Review (PDF). The Israel Journal of Psychiatry and Related Sciences. 51 (4): 296—301. 2014. PMID 25841228. {{cite journal}}: Недійсний |displayauthors=G Lerner A, Rudinski D, Bor O, Goodman C (довідка)
Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports (PDF). The Israel Journal of Psychiatry and Related Sciences. 51 (4): 277—280. 2014. PMID 25841224. {{cite journal}}: Недійсний |displayauthors=G Lerner A, Goodman C, Bor O, Lev-Ran S (довідка)

doi.org

On Perception and Consciousness in HPPD: A Systematic Review. Frontiers in Neuroscience. 15: 675768. 2021. doi:10.3389/fnins.2021.675768. PMC 8385145. PMID 34456666. {{cite journal}}: Недійсний |displayauthors=Vis PJ, Goudriaan AE, Ter Meulen BC, Blom JD (довідка)
Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sciences. 8 (3): 47. March 2018. doi:10.3390/brainsci8030047. PMC 5870365. PMID 29547576. {{cite journal}}: Недійсний |displayauthors=Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano MC, Lorusso M, di Giannantonio M, Lerner AG (довідка)
Ophthalmological assessment of cannabis-induced persisting perception disorder: is there a direct retinal effect?. Documenta Ophthalmologica. Advances in Ophthalmology. 130 (2): 121—130. April 2015. doi:10.1007/s10633-015-9481-2. PMID 25612939. {{cite journal}}: Недійсний |displayauthors=Zobor D, Strasser T, Zobor G, Schober F, Messias A, Strauss O, Batra A, Zrenner E (довідка)
Psychedelics and mental health: a population study. PLOS ONE. 8 (8): e63972. 19 серпня 2013. Bibcode:2013PLoSO...863972K. doi:10.1371/journal.pone.0063972. PMC 3747247. PMID 23976938. {{cite journal}}: Недійсний |displayauthors=Krebs TS, Johansen PØ (довідка)
A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences. Т. 36. 2016. с. 333—360. doi:10.1007/7854_2016_457. ISBN 978-3-662-55878-2. PMID 27822679.
Hallucinogen persisting perception disorder: what do we know after 50 years?. Drug and Alcohol Dependence. 69 (2): 109—119. March 2003. doi:10.1016/s0376-8716(02)00306-x. PMID 12609692. {{cite journal}}: Недійсний |displayauthors=Halpern JH, Pope HG (довідка)
The therapeutic value of lysergic acid diethylamide in mental illness. The Journal of Mental Science. 100 (419): 491—507. April 1954. doi:10.1192/bjp.100.419.491. PMID 13175011. {{cite journal}}: Недійсний |displayauthors=Sandison RA, Spencer AM, Whitelaw JD (довідка)
Further observations on untoward reactions to LSD. The American Journal of Psychiatry. 124 (3): 393—395. September 1967. doi:10.1176/ajp.124.3.393. PMID 6066637. {{cite journal}}: Недійсний |displayauthors=Robbins E, Frosch WA, Stern M (довідка)
Flashbacks: recurrent intrusive images after the use of LSD. The American Journal of Psychiatry. 126 (4): 565—569. October 1969. doi:10.1176/ajp.126.4.565. PMID 5806803. {{cite journal}}: Недійсний |displayauthors=Horowitz MJ (довідка)
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Psychopharmacology. 239 (6): 1933—1943. June 2022. doi:10.1007/s00213-022-06066-z. PMC 9166883. PMID 35076721. {{cite journal}}: Недійсний |displayauthors=Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S (довідка)
Visual phenomenology of the LSD flashback. Archives of General Psychiatry. 40 (8): 884—889. August 1983. doi:10.1001/archpsyc.1983.01790070074009. PMID 6135405. {{cite journal}}: Недійсний |displayauthors=Abraham HD (довідка)
Impaired perceptual processing and conceptual cognition in patients with anxiety disorders: a pilot study with the binocular depth inversion paradigm. Psychology, Health & Medicine. 18 (3): 363—374. 2013. doi:10.1080/13548506.2012.722649. PMID 23186162. {{cite journal}}: Недійсний |displayauthors=Passie T, Schneider U, Borsutzky M, Breyer R, Emrich HM, Bandelow B, Schmid-Ott G (довідка)
Post-traumatic stress disorder and vision. Optometry. St. Louis, Mo. 81 (5): 240—52. May 2010. doi:10.1016/j.optm.2009.07.017. PMID 20435270. {{cite journal}}: Недійсний |displayauthors=Trachtman JN (довідка)
De-constructing depersonalization: further evidence for symptom clusters. Psychiatry Research. 157 (1–3): 303—306. January 2008. doi:10.1016/j.psychres.2007.07.007. PMID 17959254. {{cite journal}}: Недійсний |displayauthors=Simeon D, Kozin DS, Segal K, Lerch B, Dujour R, Giesbrecht T (довідка)
A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Current Topics in Behavioral Neurosciences. 36: 333—360. 2018. doi:10.1007/7854_2016_457. ISBN 978-3-662-55878-2. PMID 27822679. {{cite journal}}: Недійсний |displayauthors=Halpern JH, Lerner AG, Passie T (довідка)
Therapeutic Applications of Classic Hallucinogens. Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences. Т. 36. 2016. с. 361—391. doi:10.1007/7854_2016_464. ISBN 978-3-662-55878-2. PMID 28512684.
Flashbacks und anhaltende Wahrnehmungsstörungen nach Einnahme von serotonergen Halluzinogenen. Handbuch Psychoaktive Substanzen [Flashbacks and persistent perceptual disturbances after ingestion of serotonergic hallucinogens] (нім.). 2016. с. 1—13. doi:10.1007/978-3-642-55214-4_63-1. ISBN 978-3-642-55214-4.
Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2: Review of the Evidence. The Journal of Clinical Psychiatry. 82 (3). February 2021. doi:10.4088/JCP.20ac13787. PMID 33988930. {{cite journal}}: Недійсний |displayauthors=Hosanagar A, Cusimano J, Radhakrishnan R (довідка)
Adverse consequences of lysergic acid diethylamide. Addiction. 88 (10): 1327—1334. October 1993. doi:10.1111/j.1360-0443.1993.tb02018.x. PMID 8251869. {{cite journal}}: Недійсний |displayauthors=Abraham HD, Aldridge AM (довідка)
Stable quantitative EEG difference in post-LSD visual disorder by split-half analysis: evidence for disinhibition. Psychiatry Research. 67 (3): 173—187. October 1996. doi:10.1016/0925-4927(96)02833-8. PMID 8912957. {{cite journal}}: Недійсний |displayauthors=Abraham HD, Duffy FH (довідка)
EEG coherence in post-LSD visual hallucinations. Psychiatry Research. 107 (3): 151—163. October 2001. doi:10.1016/S0925-4927(01)00098-1. PMID 11566431. {{cite journal}}: Недійсний |displayauthors=Abraham HD, Duffy FH (довідка)
LSD has high efficacy relative to serotonin in enhancing the cationic current Ih: intracellular studies in rat facial motoneurons. Synapse. 13 (2): 123—134. February 1993. doi:10.1002/syn.890130205. PMID 8446921. {{cite journal}}: Недійсний |displayauthors=Garratt JC, Alreja M, Aghajanian GK (довідка)
The relation between migraine, typical migraine aura and "visual snow". Headache. 54 (6): 957—966. June 2014. doi:10.1111/head.12378. PMID 24816400. {{cite journal}}: Недійсний |displayauthors=Schankin CJ, Maniyar FH, Sprenger T, Chou DE, Eller M, Goadsby PJ (довідка)
Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology. 48 (1): 104—112. January 2023. doi:10.1038/s41386-022-01389-z. PMC 9700802. PMID 36123427. {{cite journal}}: Недійсний |displayauthors=Calder AE, Hasler G (довідка)
Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval. NeuroImage. 236: 118039. August 2021. doi:10.1016/j.neuroimage.2021.118039. PMC 7610799. PMID 33852940. {{cite journal}}: Недійсний |displayauthors=Reed MB, Vanicek T, Seiger R, Klöbl M, Spurny B, Handschuh P, Ritter V, Unterholzner J, Godbersen GM, Gryglewski G, Kraus C, Winkler D, Hahn A, Lanzenberger R (довідка)
A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology. 147 (2): 200—209. November 1999. doi:10.1007/s002130051161. PMID 10591888. {{cite journal}}: Недійсний |displayauthors=Mintzer MZ, Stoller KB, Griffiths RR (довідка)
Apophenia, absorption and anxiety: Evidence for individual differences in positive and negative experiences of Hallucinogen Persisting Perceptual Disorder. Journal of Psychedelic Studies. 6 (2): 88—103. September 2022. doi:10.1556/2054.2022.00195. {{cite journal}}: Недійсний |displayauthors=Irvine A, Luke D (довідка)
[Hallucinogen Persisting Perception Disorder (HPPD) and Flashback Phenomena – Differential Diagnosis and Explanation Models]. Fortschritte der Neurologie-Psychiatrie. 83 (9): 506—515. September 2015. doi:10.1055/s-0035-1553717. PMID 26421858. {{cite journal}}: Недійсний |displayauthors=Hermle L, Ruchsow M, Täschner KL (довідка)
Improvement of hallucinogen persisting perception disorder (HPPD) with oral risperidone: case report. Irish Journal of Psychological Medicine. 31 (1): 47—49. March 2014. doi:10.1017/ipm.2013.59. PMID 30189471. {{cite journal}}: Недійсний |displayauthors=Subramanian N, Doran M (довідка)
LSD-like panic from risperidone in post-LSD visual disorder. Journal of Clinical Psychopharmacology. 16 (3): 238—241. June 1996. doi:10.1097/00004714-199606000-00008. PMID 8784656. {{cite journal}}: Недійсний |displayauthors=Abraham HD, Mamen A (довідка)
Hallucinogen-persisting perception disorder. Therapeutic Advances in Psychopharmacology. 2 (5): 199—205. October 2012. doi:10.1177/2045125312451270. PMC 3736944. PMID 23983976. {{cite journal}}: Недійсний |displayauthors=Hermle L, Simon M, Ruchsow M, Geppert M (довідка)
LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. International Clinical Psychopharmacology. 15 (1): 35—37. January 2000. doi:10.1097/00004850-200015010-00005. PMID 10836284. {{cite journal}}: Недійсний |displayauthors=Lerner AG, Gelkopf M, Oyffe I, Finkel B, Katz S, Sigal M, Weizman A (довідка)
Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. International Clinical Psychopharmacology. 18 (2): 101—105. March 2003. doi:10.1097/00004850-200303000-00007. PMID 12598822. {{cite journal}}: Недійсний |displayauthors=Lerner AG, Gelkopf M, Skladman I, Rudinski D, Nachshon H, Bleich A (довідка)
Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report. Frontiers in Psychiatry. 13: 867314. 2022. doi:10.3389/fpsyt.2022.867314. PMC 8987195. PMID 35401281. {{cite journal}}: Недійсний |displayauthors=Haslacher D, Novkovic N, Buthut M, Heinz A, Soekadar SR (довідка)
Behavior therapy to extinguish spontaneous recurrences of LSD effects: a case study. The Journal of Nervous and Mental Disease. 156 (4): 226—231. April 1973. doi:10.1097/00005053-197304000-00002. PMID 4708882. {{cite journal}}: Недійсний |displayauthors=Matefy RE (довідка), Behavior therapies in the treatment of drug abuse: Some case studies. The Psychological Record. 23 (2): 179—184. April 1973. doi:10.1007/BF03394152. {{cite journal}}: Недійсний |displayauthors=Spevack M, Pihl R, Rowan T (довідка)
Introduction to Part II. The thaw : reclaiming the person for psychiatry (вид. 2nd, rev. & expanded). Hillsdale, NJ: Analytic Press. 2002. doi:10.4324/9780203767238. ISBN 978-0-203-76723-8.
Cognitive Behavioral Therapy of Patients with Somatic Symptoms-Diagnostic and Therapeutic Difficulties. Journal of Clinical Medicine. 10 (14): 3159. July 2021. doi:10.3390/jcm10143159. PMC 8307926. PMID 34300324. {{cite journal}}: Недійсний |displayauthors=Orzechowska A, Maruszewska P, Gałecki P (довідка)
Cognitive-behaviour therapy for depersonalisation disorder: an open study. Behaviour Research and Therapy. 43 (9): 1121—1130. September 2005. doi:10.1016/j.brat.2004.08.003. PMID 16005701. {{cite journal}}: Недійсний |displayauthors=Hunter EC, Baker D, Phillips ML, Sierra M, David AS (довідка)
Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behaviour Research and Therapy. 41 (12): 1451—1467. December 2003. doi:10.1016/s0005-7967(03)00066-4. PMID 14583413. {{cite journal}}: Недійсний |displayauthors=Hunter EC, Phillips ML, Chalder T, Sierra M, David AS (довідка)
Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug and Alcohol Dependence. 114 (1): 61—67. March 2011. doi:10.1016/j.drugalcdep.2010.09.006. PMID 21035275. {{cite journal}}: Недійсний |displayauthors=Baggott MJ, Coyle JR, Erowid E, Erowid F, Robertson LC (довідка)

harvard.edu

ui.adsabs.harvard.edu

Psychedelics and mental health: a population study. PLOS ONE. 8 (8): e63972. 19 серпня 2013. Bibcode:2013PLoSO...863972K. doi:10.1371/journal.pone.0063972. PMC 3747247. PMID 23976938. {{cite journal}}: Недійсний |displayauthors=Krebs TS, Johansen PØ (довідка)

neurogroup.org

The Neurosensory Research Foundation (NRF).

nih.gov

pubmed.ncbi.nlm.nih.gov

On Perception and Consciousness in HPPD: A Systematic Review. Frontiers in Neuroscience. 15: 675768. 2021. doi:10.3389/fnins.2021.675768. PMC 8385145. PMID 34456666. {{cite journal}}: Недійсний |displayauthors=Vis PJ, Goudriaan AE, Ter Meulen BC, Blom JD (довідка)
Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sciences. 8 (3): 47. March 2018. doi:10.3390/brainsci8030047. PMC 5870365. PMID 29547576. {{cite journal}}: Недійсний |displayauthors=Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano MC, Lorusso M, di Giannantonio M, Lerner AG (довідка)
Ophthalmological assessment of cannabis-induced persisting perception disorder: is there a direct retinal effect?. Documenta Ophthalmologica. Advances in Ophthalmology. 130 (2): 121—130. April 2015. doi:10.1007/s10633-015-9481-2. PMID 25612939. {{cite journal}}: Недійсний |displayauthors=Zobor D, Strasser T, Zobor G, Schober F, Messias A, Strauss O, Batra A, Zrenner E (довідка)
Psychedelics and mental health: a population study. PLOS ONE. 8 (8): e63972. 19 серпня 2013. Bibcode:2013PLoSO...863972K. doi:10.1371/journal.pone.0063972. PMC 3747247. PMID 23976938. {{cite journal}}: Недійсний |displayauthors=Krebs TS, Johansen PØ (довідка)
A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences. Т. 36. 2016. с. 333—360. doi:10.1007/7854_2016_457. ISBN 978-3-662-55878-2. PMID 27822679.
Hallucinogen persisting perception disorder: what do we know after 50 years?. Drug and Alcohol Dependence. 69 (2): 109—119. March 2003. doi:10.1016/s0376-8716(02)00306-x. PMID 12609692. {{cite journal}}: Недійсний |displayauthors=Halpern JH, Pope HG (довідка)
The therapeutic value of lysergic acid diethylamide in mental illness. The Journal of Mental Science. 100 (419): 491—507. April 1954. doi:10.1192/bjp.100.419.491. PMID 13175011. {{cite journal}}: Недійсний |displayauthors=Sandison RA, Spencer AM, Whitelaw JD (довідка)
Further observations on untoward reactions to LSD. The American Journal of Psychiatry. 124 (3): 393—395. September 1967. doi:10.1176/ajp.124.3.393. PMID 6066637. {{cite journal}}: Недійсний |displayauthors=Robbins E, Frosch WA, Stern M (довідка)
Flashbacks: recurrent intrusive images after the use of LSD. The American Journal of Psychiatry. 126 (4): 565—569. October 1969. doi:10.1176/ajp.126.4.565. PMID 5806803. {{cite journal}}: Недійсний |displayauthors=Horowitz MJ (довідка)
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Psychopharmacology. 239 (6): 1933—1943. June 2022. doi:10.1007/s00213-022-06066-z. PMC 9166883. PMID 35076721. {{cite journal}}: Недійсний |displayauthors=Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S (довідка)
Visual phenomenology of the LSD flashback. Archives of General Psychiatry. 40 (8): 884—889. August 1983. doi:10.1001/archpsyc.1983.01790070074009. PMID 6135405. {{cite journal}}: Недійсний |displayauthors=Abraham HD (довідка)
Impaired perceptual processing and conceptual cognition in patients with anxiety disorders: a pilot study with the binocular depth inversion paradigm. Psychology, Health & Medicine. 18 (3): 363—374. 2013. doi:10.1080/13548506.2012.722649. PMID 23186162. {{cite journal}}: Недійсний |displayauthors=Passie T, Schneider U, Borsutzky M, Breyer R, Emrich HM, Bandelow B, Schmid-Ott G (довідка)
Post-traumatic stress disorder and vision. Optometry. St. Louis, Mo. 81 (5): 240—52. May 2010. doi:10.1016/j.optm.2009.07.017. PMID 20435270. {{cite journal}}: Недійсний |displayauthors=Trachtman JN (довідка)
De-constructing depersonalization: further evidence for symptom clusters. Psychiatry Research. 157 (1–3): 303—306. January 2008. doi:10.1016/j.psychres.2007.07.007. PMID 17959254. {{cite journal}}: Недійсний |displayauthors=Simeon D, Kozin DS, Segal K, Lerch B, Dujour R, Giesbrecht T (довідка)
A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Current Topics in Behavioral Neurosciences. 36: 333—360. 2018. doi:10.1007/7854_2016_457. ISBN 978-3-662-55878-2. PMID 27822679. {{cite journal}}: Недійсний |displayauthors=Halpern JH, Lerner AG, Passie T (довідка)
Therapeutic Applications of Classic Hallucinogens. Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences. Т. 36. 2016. с. 361—391. doi:10.1007/7854_2016_464. ISBN 978-3-662-55878-2. PMID 28512684.
Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2: Review of the Evidence. The Journal of Clinical Psychiatry. 82 (3). February 2021. doi:10.4088/JCP.20ac13787. PMID 33988930. {{cite journal}}: Недійсний |displayauthors=Hosanagar A, Cusimano J, Radhakrishnan R (довідка)
Adverse consequences of lysergic acid diethylamide. Addiction. 88 (10): 1327—1334. October 1993. doi:10.1111/j.1360-0443.1993.tb02018.x. PMID 8251869. {{cite journal}}: Недійсний |displayauthors=Abraham HD, Aldridge AM (довідка)
Flashbacks and HPPD: A Clinical-oriented Concise Review (PDF). The Israel Journal of Psychiatry and Related Sciences. 51 (4): 296—301. 2014. PMID 25841228. {{cite journal}}: Недійсний |displayauthors=G Lerner A, Rudinski D, Bor O, Goodman C (довідка)
Stable quantitative EEG difference in post-LSD visual disorder by split-half analysis: evidence for disinhibition. Psychiatry Research. 67 (3): 173—187. October 1996. doi:10.1016/0925-4927(96)02833-8. PMID 8912957. {{cite journal}}: Недійсний |displayauthors=Abraham HD, Duffy FH (довідка)
EEG coherence in post-LSD visual hallucinations. Psychiatry Research. 107 (3): 151—163. October 2001. doi:10.1016/S0925-4927(01)00098-1. PMID 11566431. {{cite journal}}: Недійсний |displayauthors=Abraham HD, Duffy FH (довідка)
LSD has high efficacy relative to serotonin in enhancing the cationic current Ih: intracellular studies in rat facial motoneurons. Synapse. 13 (2): 123—134. February 1993. doi:10.1002/syn.890130205. PMID 8446921. {{cite journal}}: Недійсний |displayauthors=Garratt JC, Alreja M, Aghajanian GK (довідка)
Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. The Journal of Pharmacology and Experimental Therapeutics. 246 (3): 924—928. September 1988. PMID 2843634. {{cite journal}}: Недійсний |displayauthors=Sanders-Bush E, Burris KD, Knoth K (довідка)
The relation between migraine, typical migraine aura and "visual snow". Headache. 54 (6): 957—966. June 2014. doi:10.1111/head.12378. PMID 24816400. {{cite journal}}: Недійсний |displayauthors=Schankin CJ, Maniyar FH, Sprenger T, Chou DE, Eller M, Goadsby PJ (довідка)
Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology. 48 (1): 104—112. January 2023. doi:10.1038/s41386-022-01389-z. PMC 9700802. PMID 36123427. {{cite journal}}: Недійсний |displayauthors=Calder AE, Hasler G (довідка)
Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval. NeuroImage. 236: 118039. August 2021. doi:10.1016/j.neuroimage.2021.118039. PMC 7610799. PMID 33852940. {{cite journal}}: Недійсний |displayauthors=Reed MB, Vanicek T, Seiger R, Klöbl M, Spurny B, Handschuh P, Ritter V, Unterholzner J, Godbersen GM, Gryglewski G, Kraus C, Winkler D, Hahn A, Lanzenberger R (довідка)
A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology. 147 (2): 200—209. November 1999. doi:10.1007/s002130051161. PMID 10591888. {{cite journal}}: Недійсний |displayauthors=Mintzer MZ, Stoller KB, Griffiths RR (довідка)
[Hallucinogen Persisting Perception Disorder (HPPD) and Flashback Phenomena – Differential Diagnosis and Explanation Models]. Fortschritte der Neurologie-Psychiatrie. 83 (9): 506—515. September 2015. doi:10.1055/s-0035-1553717. PMID 26421858. {{cite journal}}: Недійсний |displayauthors=Hermle L, Ruchsow M, Täschner KL (довідка)
Improvement of hallucinogen persisting perception disorder (HPPD) with oral risperidone: case report. Irish Journal of Psychological Medicine. 31 (1): 47—49. March 2014. doi:10.1017/ipm.2013.59. PMID 30189471. {{cite journal}}: Недійсний |displayauthors=Subramanian N, Doran M (довідка)
LSD-like panic from risperidone in post-LSD visual disorder. Journal of Clinical Psychopharmacology. 16 (3): 238—241. June 1996. doi:10.1097/00004714-199606000-00008. PMID 8784656. {{cite journal}}: Недійсний |displayauthors=Abraham HD, Mamen A (довідка)
Hallucinogen-persisting perception disorder. Therapeutic Advances in Psychopharmacology. 2 (5): 199—205. October 2012. doi:10.1177/2045125312451270. PMC 3736944. PMID 23983976. {{cite journal}}: Недійсний |displayauthors=Hermle L, Simon M, Ruchsow M, Geppert M (довідка)
LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. International Clinical Psychopharmacology. 15 (1): 35—37. January 2000. doi:10.1097/00004850-200015010-00005. PMID 10836284. {{cite journal}}: Недійсний |displayauthors=Lerner AG, Gelkopf M, Oyffe I, Finkel B, Katz S, Sigal M, Weizman A (довідка)
Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports (PDF). The Israel Journal of Psychiatry and Related Sciences. 51 (4): 277—280. 2014. PMID 25841224. {{cite journal}}: Недійсний |displayauthors=G Lerner A, Goodman C, Bor O, Lev-Ran S (довідка)
Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. International Clinical Psychopharmacology. 18 (2): 101—105. March 2003. doi:10.1097/00004850-200303000-00007. PMID 12598822. {{cite journal}}: Недійсний |displayauthors=Lerner AG, Gelkopf M, Skladman I, Rudinski D, Nachshon H, Bleich A (довідка)
Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report. Frontiers in Psychiatry. 13: 867314. 2022. doi:10.3389/fpsyt.2022.867314. PMC 8987195. PMID 35401281. {{cite journal}}: Недійсний |displayauthors=Haslacher D, Novkovic N, Buthut M, Heinz A, Soekadar SR (довідка)
Behavior therapy to extinguish spontaneous recurrences of LSD effects: a case study. The Journal of Nervous and Mental Disease. 156 (4): 226—231. April 1973. doi:10.1097/00005053-197304000-00002. PMID 4708882. {{cite journal}}: Недійсний |displayauthors=Matefy RE (довідка), Behavior therapies in the treatment of drug abuse: Some case studies. The Psychological Record. 23 (2): 179—184. April 1973. doi:10.1007/BF03394152. {{cite journal}}: Недійсний |displayauthors=Spevack M, Pihl R, Rowan T (довідка)
Cognitive Behavioral Therapy of Patients with Somatic Symptoms-Diagnostic and Therapeutic Difficulties. Journal of Clinical Medicine. 10 (14): 3159. July 2021. doi:10.3390/jcm10143159. PMC 8307926. PMID 34300324. {{cite journal}}: Недійсний |displayauthors=Orzechowska A, Maruszewska P, Gałecki P (довідка)
Cognitive-behaviour therapy for depersonalisation disorder: an open study. Behaviour Research and Therapy. 43 (9): 1121—1130. September 2005. doi:10.1016/j.brat.2004.08.003. PMID 16005701. {{cite journal}}: Недійсний |displayauthors=Hunter EC, Baker D, Phillips ML, Sierra M, David AS (довідка)
Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behaviour Research and Therapy. 41 (12): 1451—1467. December 2003. doi:10.1016/s0005-7967(03)00066-4. PMID 14583413. {{cite journal}}: Недійсний |displayauthors=Hunter EC, Phillips ML, Chalder T, Sierra M, David AS (довідка)
Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug and Alcohol Dependence. 114 (1): 61—67. March 2011. doi:10.1016/j.drugalcdep.2010.09.006. PMID 21035275. {{cite journal}}: Недійсний |displayauthors=Baggott MJ, Coyle JR, Erowid E, Erowid F, Robertson LC (довідка)

ncbi.nlm.nih.gov

On Perception and Consciousness in HPPD: A Systematic Review. Frontiers in Neuroscience. 15: 675768. 2021. doi:10.3389/fnins.2021.675768. PMC 8385145. PMID 34456666. {{cite journal}}: Недійсний |displayauthors=Vis PJ, Goudriaan AE, Ter Meulen BC, Blom JD (довідка)
Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sciences. 8 (3): 47. March 2018. doi:10.3390/brainsci8030047. PMC 5870365. PMID 29547576. {{cite journal}}: Недійсний |displayauthors=Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano MC, Lorusso M, di Giannantonio M, Lerner AG (довідка)
Psychedelics and mental health: a population study. PLOS ONE. 8 (8): e63972. 19 серпня 2013. Bibcode:2013PLoSO...863972K. doi:10.1371/journal.pone.0063972. PMC 3747247. PMID 23976938. {{cite journal}}: Недійсний |displayauthors=Krebs TS, Johansen PØ (довідка)
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Psychopharmacology. 239 (6): 1933—1943. June 2022. doi:10.1007/s00213-022-06066-z. PMC 9166883. PMID 35076721. {{cite journal}}: Недійсний |displayauthors=Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S (довідка)
Exhibit 1.3-4, DSM-5 Diagnostic Criteria for PTSD. Treatment Improvement Protocol (TIP) Series, No. 57. Center for Substance Abuse Treatment (US). Trauma-Informed Care in Behavioral Health Services. Rockville (MD): Substance Abuse and Mental Health Services Administration (US). 2014.
Table 3.10, Panic Disorder and Agoraphobia Criteria Changes from DSM-IV to DSM-5. Treatment Improvement Protocol (TIP) Series, No. 57. Center for Substance Abuse Treatment (US). Trauma-Informed Care in Behavioral Health Services. Rockville (MD): Substance Abuse and Mental Health Services Administration (US). 2016.
Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology. 48 (1): 104—112. January 2023. doi:10.1038/s41386-022-01389-z. PMC 9700802. PMID 36123427. {{cite journal}}: Недійсний |displayauthors=Calder AE, Hasler G (довідка)
Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval. NeuroImage. 236: 118039. August 2021. doi:10.1016/j.neuroimage.2021.118039. PMC 7610799. PMID 33852940. {{cite journal}}: Недійсний |displayauthors=Reed MB, Vanicek T, Seiger R, Klöbl M, Spurny B, Handschuh P, Ritter V, Unterholzner J, Godbersen GM, Gryglewski G, Kraus C, Winkler D, Hahn A, Lanzenberger R (довідка)
Hallucinogen-persisting perception disorder. Therapeutic Advances in Psychopharmacology. 2 (5): 199—205. October 2012. doi:10.1177/2045125312451270. PMC 3736944. PMID 23983976. {{cite journal}}: Недійсний |displayauthors=Hermle L, Simon M, Ruchsow M, Geppert M (довідка)
Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report. Frontiers in Psychiatry. 13: 867314. 2022. doi:10.3389/fpsyt.2022.867314. PMC 8987195. PMID 35401281. {{cite journal}}: Недійсний |displayauthors=Haslacher D, Novkovic N, Buthut M, Heinz A, Soekadar SR (довідка)
Cognitive Behavioral Therapy of Patients with Somatic Symptoms-Diagnostic and Therapeutic Difficulties. Journal of Clinical Medicine. 10 (14): 3159. July 2021. doi:10.3390/jcm10143159. PMC 8307926. PMID 34300324. {{cite journal}}: Недійсний |displayauthors=Orzechowska A, Maruszewska P, Gałecki P (довідка)

perception.foundation

Perception Restoration Foundation.
Specialists Directory. The Perception Restoration Foundation.

rarediseases.org

Visual Snow Syndrome. National Organization for Rare Disorders, Inc.

thecut.com

A Power Trip Refresher. The Cut. 16 березня 2022.

visualsnowinitiative.org

New Study: Antidepressants, Vision Problems, & VSS!. 20 березня 2022.
Visual Snow Initiative.

youtube.com

Documenting America's Underbelly - ALL GAS NO BRAKES (video) (англ.). Vice. 21 січня 2021. На 20:48-21:49 хвилині. Процитовано 24 січня 2021.
SuperMegaCast - EP 324: Ram Ranch (ft. bbno$) (video) (англ.). SuperMega. 4 грудня 2022. На 57:08-58:00 хвилині. Процитовано 25 січня 2023.